Home Mix categorized Manulife Amends its Normal Course Issuer Bid to Repurchase for Cancellation up...

Manulife Amends its Normal Course Issuer Bid to Repurchase for Cancellation up to an Additional 59 Million of its Common Shares


TORONTO – Manulife Financial Corporation (“Manulife”) announced today that the Toronto Stock Exchange (“TSX”) has approved Manulife’s amended normal course issuer bid (“NCIB”). As previously announced, the purpose of the amendment is to increase the number of common shares that Manulife may repurchase from 40 million (approximately 2% of Manulife’s 1,984,717,416 issued and outstanding shares as at October 31, 2018) to 99 million (approximately 5% of shares outstanding as at October 31, 2018). Manulife has completed the repurchase of 30,586,449 common shares for cancellation since the commencement of its current NCIB, at a volume weighted average repurchase price per common share of $20.5244. To date, all repurchases have been made through the facilities of the TSX and the CHI-X. No other terms of the NCIB are amended. The Office of the Superintendent of Financial Institutions previously approved the amended NCIB. The effective date of the amendment is February 22, 2019.

Under the NCIB, Manulife may purchase up to 890,155 of its common shares on the TSX during any trading day, which represents 25% of the average daily trading volume of 3,560,621 common shares on the TSX for the six months ended October 31, 2018, subject to TSX rules permitting block purchases.

Manulife believes that the purchase of Manulife common shares at recent market prices is an appropriate investment by Manulife since, in its view, recent market prices do not reflect the underlying value of Manulife’s business. Continuing to have an NCIB in place will provide Manulife with the flexibility to purchase common shares as part of its capital management strategy which is designed to maintain healthy regulatory capital ratios while balancing the objective of generating shareholder value. The actual number of common shares purchased, the timing of such purchases and the price at which common shares are purchased will be determined by Manulife.

Manulife’s current normal course issuer bid commenced on November 14, 2018 and will continue until November 13, 2019, when the NCIB expires, or such earlier date as Manulife completes its purchases. Purchases under the NCIB may be made through the facilities of the TSX, the New York Stock Exchange, other designated exchanges and alternative trading systems in Canada and the United States at market prices prevailing at the time of purchase or such other price as may be permitted. All common shares acquired by Manulife under the NCIB will be cancelled. Repurchases will be subject to compliance with applicable Canadian securities laws and United States federal securities laws.

In addition, Manulife may undertake repurchases of its common shares outside of Canada and the United States in compliance with applicable laws. Subject to regulatory approval, Manulife may also acquire common shares directly from other holders by way of private agreement pursuant to issuer bid exemption orders issued by applicable securities regulatory authorities. Any private purchase made under an exemption order issued by a securities regulatory authority will generally be at a discount to the prevailing market price. Manulife may also enter into derivative-based programs in support of its repurchase activities, including the writing of put options and forward purchase agreements, accelerated share repurchase transactions, other equity contracts or use other methods of acquiring shares, in each case subject to regulatory approval and on such terms and at such times as shall be permitted by applicable securities laws. The total number of common shares repurchased under the NCIB and all other potential arrangements will not exceed 99 million common shares.

Manulife previously entered into an automatic share repurchase plan under which its designated broker will repurchase Manulife’s common shares pursuant to the NCIB, and the automatic plan will continue to apply to the amended NCIB. The actual number of common shares purchased under the automatic plan, the timing of such purchases and the price at which common shares are purchased will depend upon future market conditions. The automatic plan, which was pre-cleared by the TSX, provides for the potential repurchase of common shares at any time, including when Manulife ordinarily would not be active in the market due to its own internal trading blackout periods, insider trading rules, or otherwise.


Please enter your comment!
Please enter your name here